Ascendis Pharma A/S
Biopharma using proprietary TransCon® tech to develop therapies for rare diseases & oncology.
ASND | NDAQ
Overview
Corporate Details
- ISIN(s):
- US04351P1012
- LEI:
- Country:
- United States of America
- Address:
- TUBORG BOULEVARD 12, 0 HELLERUP
- Website:
- https://ascendispharma.dk/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Ascendis Pharma A/S, founded in 2007, is a global biopharmaceutical company applying its proprietary TransCon® technology platform to develop innovative therapies for unmet medical needs. The company aims to build a leading, fully integrated biopharmaceutical business focused on making a meaningful difference in patients' lives. Its primary therapeutic areas of focus include endocrinology, rare diseases, and oncology. The development pipeline features multiple product candidates, including three in clinical development for rare endocrinological diseases and several assets in oncology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Ascendis Pharma A/S filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Ascendis Pharma A/S
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Ascendis Pharma A/S via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
